The elevated serum interleukin-6 correlates with the increased serum butyrate level in patients with nasopharyngeal carcinoma

Kuan Chih Chow, Shiow Her Chiou, Shu Peng Ho, Ming Hsui Tsai, Chi Long Chen, Liang Shun Wang, Kwan Hwa Chi

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

We investigated the clinical significance and regulation of serum interleukin-6 (IL-6) in patients with nasopharyngeal carcinoma (NPC). Serum IL-6 levels of 314 NPC patients and 202 healthy individuals were determined. Of the NPC patients, 69.1% (217/314) showed higher IL-6 levels than that of normal average (2.76±2.06 pg/ml). Elevation of IL-6 correlated with the advanced disease and the adverse prognosis of NPC patients. By employing in situ hybridization technique, IL-6 mRNA was detected in the tumor cells of NPC patients with high serum IL-6 levels. Concurrently, serum levels of butyrate were determined in 147 NPC patients and 52 healthy individuals by gas chromatography. Patients with elevated serum butyrate concentrations (4.2±2.2 μM) also had significantly higher IL-6 levels (29.14±5.17 pg/ml). No detectable serum butyrate was measured in the healthy individuals. In order to investigate the direct relationship between butyrate and IL-6, n-sodium butyrate (n-BT) was added to the NPC cells in an in vitro study, and marked increase of IL-6 expression was detected in n-BT-treated cells. Our results suggested that tumor cells could be an important source of elevated serum IL-6 in patients with NPC and that IL-6 level in NPC patients was proportional to the serum butyrate concentration. In vitro, IL-6 expression in NPC cells could be up-regulated by butyrate.

Original languageEnglish
Pages (from-to)813-819
Number of pages7
JournalOncology Reports
Volume10
Issue number4
Publication statusPublished - Jul 2003
Externally publishedYes

Fingerprint

Butyrates
Interleukin-6
Serum
Butyric Acid
Nasopharyngeal carcinoma
Gas Chromatography
In Situ Hybridization
Neoplasms

Keywords

  • Interleukin-6 (IL-6)
  • n-sodium butyrate (n-BT)
  • Nasopharyngeal carcinoma (NPC)

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Chow, K. C., Chiou, S. H., Ho, S. P., Tsai, M. H., Chen, C. L., Wang, L. S., & Chi, K. H. (2003). The elevated serum interleukin-6 correlates with the increased serum butyrate level in patients with nasopharyngeal carcinoma. Oncology Reports, 10(4), 813-819.

The elevated serum interleukin-6 correlates with the increased serum butyrate level in patients with nasopharyngeal carcinoma. / Chow, Kuan Chih; Chiou, Shiow Her; Ho, Shu Peng; Tsai, Ming Hsui; Chen, Chi Long; Wang, Liang Shun; Chi, Kwan Hwa.

In: Oncology Reports, Vol. 10, No. 4, 07.2003, p. 813-819.

Research output: Contribution to journalArticle

Chow, Kuan Chih ; Chiou, Shiow Her ; Ho, Shu Peng ; Tsai, Ming Hsui ; Chen, Chi Long ; Wang, Liang Shun ; Chi, Kwan Hwa. / The elevated serum interleukin-6 correlates with the increased serum butyrate level in patients with nasopharyngeal carcinoma. In: Oncology Reports. 2003 ; Vol. 10, No. 4. pp. 813-819.
@article{4bcd52eee1784a9ca0ccc9a7c9cf7966,
title = "The elevated serum interleukin-6 correlates with the increased serum butyrate level in patients with nasopharyngeal carcinoma",
abstract = "We investigated the clinical significance and regulation of serum interleukin-6 (IL-6) in patients with nasopharyngeal carcinoma (NPC). Serum IL-6 levels of 314 NPC patients and 202 healthy individuals were determined. Of the NPC patients, 69.1{\%} (217/314) showed higher IL-6 levels than that of normal average (2.76±2.06 pg/ml). Elevation of IL-6 correlated with the advanced disease and the adverse prognosis of NPC patients. By employing in situ hybridization technique, IL-6 mRNA was detected in the tumor cells of NPC patients with high serum IL-6 levels. Concurrently, serum levels of butyrate were determined in 147 NPC patients and 52 healthy individuals by gas chromatography. Patients with elevated serum butyrate concentrations (4.2±2.2 μM) also had significantly higher IL-6 levels (29.14±5.17 pg/ml). No detectable serum butyrate was measured in the healthy individuals. In order to investigate the direct relationship between butyrate and IL-6, n-sodium butyrate (n-BT) was added to the NPC cells in an in vitro study, and marked increase of IL-6 expression was detected in n-BT-treated cells. Our results suggested that tumor cells could be an important source of elevated serum IL-6 in patients with NPC and that IL-6 level in NPC patients was proportional to the serum butyrate concentration. In vitro, IL-6 expression in NPC cells could be up-regulated by butyrate.",
keywords = "Interleukin-6 (IL-6), n-sodium butyrate (n-BT), Nasopharyngeal carcinoma (NPC)",
author = "Chow, {Kuan Chih} and Chiou, {Shiow Her} and Ho, {Shu Peng} and Tsai, {Ming Hsui} and Chen, {Chi Long} and Wang, {Liang Shun} and Chi, {Kwan Hwa}",
year = "2003",
month = "7",
language = "English",
volume = "10",
pages = "813--819",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - The elevated serum interleukin-6 correlates with the increased serum butyrate level in patients with nasopharyngeal carcinoma

AU - Chow, Kuan Chih

AU - Chiou, Shiow Her

AU - Ho, Shu Peng

AU - Tsai, Ming Hsui

AU - Chen, Chi Long

AU - Wang, Liang Shun

AU - Chi, Kwan Hwa

PY - 2003/7

Y1 - 2003/7

N2 - We investigated the clinical significance and regulation of serum interleukin-6 (IL-6) in patients with nasopharyngeal carcinoma (NPC). Serum IL-6 levels of 314 NPC patients and 202 healthy individuals were determined. Of the NPC patients, 69.1% (217/314) showed higher IL-6 levels than that of normal average (2.76±2.06 pg/ml). Elevation of IL-6 correlated with the advanced disease and the adverse prognosis of NPC patients. By employing in situ hybridization technique, IL-6 mRNA was detected in the tumor cells of NPC patients with high serum IL-6 levels. Concurrently, serum levels of butyrate were determined in 147 NPC patients and 52 healthy individuals by gas chromatography. Patients with elevated serum butyrate concentrations (4.2±2.2 μM) also had significantly higher IL-6 levels (29.14±5.17 pg/ml). No detectable serum butyrate was measured in the healthy individuals. In order to investigate the direct relationship between butyrate and IL-6, n-sodium butyrate (n-BT) was added to the NPC cells in an in vitro study, and marked increase of IL-6 expression was detected in n-BT-treated cells. Our results suggested that tumor cells could be an important source of elevated serum IL-6 in patients with NPC and that IL-6 level in NPC patients was proportional to the serum butyrate concentration. In vitro, IL-6 expression in NPC cells could be up-regulated by butyrate.

AB - We investigated the clinical significance and regulation of serum interleukin-6 (IL-6) in patients with nasopharyngeal carcinoma (NPC). Serum IL-6 levels of 314 NPC patients and 202 healthy individuals were determined. Of the NPC patients, 69.1% (217/314) showed higher IL-6 levels than that of normal average (2.76±2.06 pg/ml). Elevation of IL-6 correlated with the advanced disease and the adverse prognosis of NPC patients. By employing in situ hybridization technique, IL-6 mRNA was detected in the tumor cells of NPC patients with high serum IL-6 levels. Concurrently, serum levels of butyrate were determined in 147 NPC patients and 52 healthy individuals by gas chromatography. Patients with elevated serum butyrate concentrations (4.2±2.2 μM) also had significantly higher IL-6 levels (29.14±5.17 pg/ml). No detectable serum butyrate was measured in the healthy individuals. In order to investigate the direct relationship between butyrate and IL-6, n-sodium butyrate (n-BT) was added to the NPC cells in an in vitro study, and marked increase of IL-6 expression was detected in n-BT-treated cells. Our results suggested that tumor cells could be an important source of elevated serum IL-6 in patients with NPC and that IL-6 level in NPC patients was proportional to the serum butyrate concentration. In vitro, IL-6 expression in NPC cells could be up-regulated by butyrate.

KW - Interleukin-6 (IL-6)

KW - n-sodium butyrate (n-BT)

KW - Nasopharyngeal carcinoma (NPC)

UR - http://www.scopus.com/inward/record.url?scp=1542577667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542577667&partnerID=8YFLogxK

M3 - Article

C2 - 12792728

AN - SCOPUS:1542577667

VL - 10

SP - 813

EP - 819

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 4

ER -